At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Jun 28, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 4,281 11.48 - 11.50
Jun 5, 2007 fhm iv lp Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,600,014 n/a
Jun 5, 2007 garden state life sciences venture fund l p Beneficial Owner (10% or more) Acquisition (Non Open Market) 1,064,822 n/a
Jun 5, 2007 garden state life sciences venture fund l p Beneficial Owner (10% or more) Acquisition (Non Open Market) 354,940 n/a
Jul 17, 2012 glaxosmithkline plc Beneficial Owner (10% or more) Buy 2,949,581 6.30
Nov 12, 2010 glaxosmithkline plc Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Mar 7, 2012 kramlich c richard Beneficial Owner (10% or more) Buy 1,140,000 5.70
Jul 25, 2007 kramlich c richard Beneficial Owner (10% or more) Acquisition (Non Open Market) 29,447 11.49
Jun 5, 2007 kramlich c richard Beneficial Owner (10% or more) Option Execute 15,077 6.38
Jun 5, 2007 kramlich c richard Beneficial Owner (10% or more) Acquisition (Non Open Market) 4,472,224 n/a
Jun 5, 2007 kramlich c richard Beneficial Owner (10% or more) Sell 6,408 15.00
Aug 18, 2008 licholai gregory p Officer Option Execute 1,401 0.64
Aug 18, 2008 licholai gregory p Officer Sell 1,401 15.11
Jul 22, 2008 licholai gregory p Officer Option Execute 15,000 0.64
Jul 22, 2008 licholai gregory p Officer Sell 15,000 15.00
Jul 15, 2008 licholai gregory p Officer Option Execute 15,000 0.64
Jul 15, 2008 licholai gregory p Officer Sell 15,000 13.00
Feb 28, 2008 licholai gregory p Officer Sell 10,000 10.00 - 10.10
Feb 1, 2008 licholai gregory p Officer Sell 10,000 9.90
May 30, 2007 licholai gregory p Officer Statement of Ownership 0 n/a
Showing 241-260 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy